Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Animal model is referred as those animals on which biological and pathological experiment are performed and tested. The animal models are used as they have similar physiological and organic structures as that of humans. Moreover, some of the animals have almost similar genetic structures as of humans. So, animal models are used by research scientists and other peoples for studying of certain diseases and treatment of that disease and test the end products before using on the humans and development of new products. Novel drugs are investigated in animals for efficacy and safety before they are examined in peoples.
The Asia Pacific humanized mouse models market is witnessing tremendous growth during the forecast period of 2019 - 2028. The animal model have extensive applications in the area of research and development, production and quality control department. The key factors such as increase in the investment in vaccine development is propelling growth of Asia Pacific humanized mouse models market. The rising demand for therapeutics against COVID-19 is also refuelling growth of Asia Pacific humanized mouse models market. However, the high cost of study is hampering growth of Asia Pacific humanized mouse models market.
The exclusive COVID-19 impact analysis report by Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the humanized mouse models market. In addition, complete analysis of changes on humanized mouse models expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period.
The Asia Pacific humanized mouse models market is segmented into the type, application, end user and country.
The Asia Pacific humanized mouse market is segmented into the cell-based humanized mouse models and genetic humanized mouse models. In which cell-based humanized mouse is also contributing to the growth of Asia Pacific humanized mouse models market. The rising prevalence of cancer is propelling growth of Asia Pacific humanized mouse models market. The increasing immunodeficiency disorders is also boosting growth of Asia Pacific humanized mouse models market.
The Asia Pacific humanized mouse models market is comprised of applications such as immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. In which haematopoiesis is also contributing to the growth of Asia Pacific humanized mouse models market. The increasing research and development activities in healthcare is propelling growth of Asia Pacific humanized mouse models market.
The Asia Pacific humanized mouse models market is comprised of end users like pharmaceutical and biotechnology companies, contract research organizations and academic and research institutes. In which pharmaceutical and biotechnology companies are estimated to dominate the market in 2020. The rising research and development activities in pharmaceutical industry is propelling growth of the market. The growing healthcare funding is also boosting growth of the market. Furthermore, rising demand for quality testing of pharmaceuticals is also refuelling growth of humanized mouse models market.
The Asia Pacific humanized mouse models market is studied for key countries such as China, India, Japan, Australia and South Korea. In which China followed by India and Japan are anticipated to dominate the market in 2020. The growing research in healthcare industry is propelling growth of Asia Pacific humanized mouse models market. The rising healthcare infrastructure is also boosting growth of Asia Pacific humanized mouse models market.
Key Players in Humanized Mouse Models Market
The major key players in humanized mouse models market are The Jackson Laboratory, Taconic Biosciences Inc., Harbour Biomed, Humurine Technologies Inc., Vitalstar Biotechnology Co. Ltd., Crown Bioscience Inc., Ingenious Targeting Laboratory, Axenis S.A.S., Trans Genic Inc. and Genoway S.A. among others.
January 2021: The Champion Oncology Inc., a well-known global oncology technology company which is transforming drug discovery and development by the data driven research strategies announced the expansion of its Lumin Bioinformatics SaaS program.
December 2020: The Perkin Elmer Inc., and Horizon Discovery Group plc announced the agreement on the terms of a recommended all-cash offer in Perkin Elmer will acquire Horizon.
January 2020: The Taconic Biosciences, a global leader in the development of drug discovery animal model has launched a new model generation facility in Leverkusen, Germany.
January 2020: The H.I.G. Capital announced that one of their affiliates has joined forces with the management team of Taconic Biosciences inc., for supporting company’s growth as the leading provider of research models and services to the pharmaceutical, biotechnology and contract research organizations.
The report analyses the humanized mouse models based on the type, application, end user and country. The various types of humanized mouse models covered in the report are genetic humanized mouse models and cell-based humanized mouse models. By Application, the market is segmented into the immunology and infectious diseases, neuroscience, oncology, haematopoiesis, toxicology and other. Based on end user, the market is segmented into the pharmaceutical and biotechnology companies, contract research organization and academic and research institutes. The report also analyses the impact of COVID-19 on the market and it found that the rising incidences of various diseases and viral infections such as COVID-19 increases the demand for humanized mouse models for research activity during COVID-19 period. The rising prevalence of infectious diseases is also boosting growth of humanized mouse models market during COVID-19 pandemics. The rising use of animal models for development of research activities is also boosting growth of humanized mouse models market during COVID-19 period. The report also analyses the major key players operating in the market.
Why to buy this report
